YOLFTbeta
Sanara Medtech Inc

Sanara Medtech Inc

SMTI · NASDAQ · Healthcare / Medical Instruments & Supplies

32.35USD-0.19 (-0.58%)

Price History

Full chart

Market Stats

Previous Close32.54
Open32.70
Day Range32.35 – 32.79
52-Week Range16.05 – 35.34
Volume25.00K
Market Cap322.50M
P/E (TTM)0.00
Forward P/E217.39
EPS-0.04
Dividend Yield0.00%
Beta1.16
50-Day Avg33.27
200-Day Avg24.31

About

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Seth D. Yon
  • Employees108
  • Headquarters1200 Summit Avenue, Fort Worth, TX, United States, 76102, USA
  • Websitehttps://sanaramedtech.com

Leadership

  • Mr. Ronald T. NixonExecutive Chairman · b. 1956
  • Mr. Seth D. YonPresident, CEO & Director · b. 1975
  • Ms. Elizabeth B. TaylorChief Financial Officer · b. 1976
  • Mr. Jacob A. WaldropChief Operating Officer · b. 1982
  • Ms. Ashley M. MackeyPrincipal Accounting Officer · b. 1986
  • Mr. Bill FitzgeraldChief Compliance Officer
  • Mr. Nicholas Gachassin IIIGeneral Counsel · b. 1967
  • Ms. Tricia MattesonVice President of Marketing
  • Mr. Tyler PalmerChief Corporate Development & Strategy Officer
  • Ms. Nina BiondaChief R&D Officer

Financials

Income Statement

Currency: USD1999-12-312000-12-312001-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.25M2.30M20.96K85.02K211.17K189.75K630.50K290.18K288.02K910.42K2.21M1.17M1.73M2.63M3.37M5.51M6.30M5.84M11.77M15.59M24.14M45.84M64.99M86.67M103.12M
Growth (%)-+2.41%-99.09%+305.64%+148.38%-10.14%+232.27%-53.98%-0.75%+216.10%+142.71%-46.89%+47.11%+52.49%+28.09%+63.33%+14.47%-7.41%+101.56%+32.47%+54.90%+89.87%+41.77%+33.36%+18.97%
Cost of Revenue1.42M1.51M19.95K79.56K271.34K193.06K223.18K417.10K1.11M538.27K799.63K798.53K792.77K803.63K891.97K943.58K806.04K507.42K1.21M1.62M2.31M6.36M7.85M8.14M10.18M
Gross Profit828.05K791.75K1.01K5.46K-60.17K-3.30K407.32K-126.92K-817.21K372.15K1.41M375.01K933.62K1.83M2.48M4.56M5.50M5.33M10.56M13.97M21.83M39.48M57.14M78.53M92.94M
Gross Margin36.79%34.35%4.82%6.42%-28.49%-1.74%64.60%-43.74%-283.73%40.88%63.81%31.96%54.08%69.47%73.55%82.87%87.22%91.31%89.72%89.63%90.43%86.12%87.92%90.61%90.13%
Operating Expense1.53M1.81M1.45M6.13M680.65K484.58K813.06K1.63M1.02M3.44M6.42M5.79M3.86M3.89M3.45M4.84M5.38M5.83M13.30M19.00M29.21M52.00M61.35M85.25M83.79M
Operating Income-702.20K-1.01M-1.45M-6.13M-740.82K-487.88K-405.74K-1.76M-1.84M-3.07M-5.01M-5.42M-2.93M-2.06M-964.98K-272.13K120.44K-501.86K-2.74M-5.03M-7.38M-12.52M-4.22M-6.72M9.15M
Operating Margin-31.20%-44.00%-6909.08%-7208.81%-350.82%-257.11%-64.35%-606.08%-639.56%-337.22%-226.95%-461.72%-169.63%-78.34%-28.62%-4.94%1.91%-8.60%-23.29%-32.30%-30.55%-27.30%-6.49%-7.75%8.87%
EBITDA-772.78K-823.51K-1.39M-1.66M-724.60K-466.10K-385.66K-1.74M-2.42M-3.82M-4.54M-469.77K-2.31M-1.93M-1.10M-180.37K538.78K-417.97K-2.61M-4.14M-7.22M-11.57M-289.10K-1.86M9.03M
EBITDA Margin-34.34%-35.73%-6617.46%-1950.93%-343.14%-245.63%-61.17%-601.26%-839.77%-420.00%-205.65%-40.03%-133.76%-73.23%-32.72%-3.27%8.55%-7.16%-22.18%-26.58%-29.91%-25.23%-0.44%-2.15%8.76%
Net Income477.58K-1.10M-1.53M-6.30M-757.86K-623.56K-542.76K-1.77M-2.30M-5.14M-12.74M-1.85M-4.15M-2.28M-1.34M-415.75K331.31K-600.57K-2.81M-4.36M-7.92M-7.94M-4.30M-9.66M-37.56M
Net Income Margin21.22%-47.80%-7299.35%-7404.62%-358.89%-328.61%-86.08%-611.06%-799.43%-564.08%-576.59%-157.24%-240.27%-86.54%-39.75%-7.55%5.25%-10.29%-23.92%-27.95%-32.81%-17.31%-6.62%-11.15%-36.43%
R&D-------------------40.19K558.70K3.37M4.13M5.70M5.07M
R&D as % of Total Revenue-------------------0.26%2.31%7.34%6.36%6.58%4.92%
Interest Expense684.08K132.00K328.33K7.76K51.09K135.67K137.02K14.45K473.28K801.78K262.34K1.22M1.79M293.90K176.89K174.49K126.83K86.59K105.92K11.53K711284.75K475.78K3.13M6.76M
Interest Expense % of Total Revenue30.40%5.73%1566.53%9.13%24.19%71.50%21.73%4.98%164.32%88.07%11.87%103.73%103.52%11.16%5.25%3.17%2.01%1.48%0.90%0.07%0.00%0.62%0.73%3.61%6.56%

Balance Sheet

Currency: USD1999-12-312000-12-312001-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.45M1.14M1.46M203.43K257.81K496.29K405.73K151.71K4.77M6.78M3.83M1.39M977.15K1.50M1.39M2.17M2.22M3.04M11.12M9.83M36.40M61.04M73.87M88.09M72.94M
Total Liabilities1.83M2.52M3.56M162.23K905.27K1.77M2.22M472.97K2.46M3.91M7.69M5.20M3.45M2.32M2.66M2.59M2.12M1.93M4.72M3.99M6.24M19.32M29.28M49.18M67.01M
Total Equity-377.38K-1.38M-2.10M41.20K-647.47K-1.27M-1.81M-321.26K2.31M2.87M-3.86M-3.81M-2.47M-825.40K-1.27M-423.07K102.54K1.11M6.61M6.15M30.64M41.83M44.83M39.40M5.93M
Cash26.08K29.91K-7.89K2.83K236.30K7811.14K-4.36K50.84K3.61K45.86K44.55K523.44K182.34K833.48K463.19K731.85K6.61M455.37K18.65M8.96M5.15M15.88M16.58M
Total Debt1.08M1.49K2.10M10.33K7.16K1.28M1.51M1.51M1.37M2.58M1.37M2.42M1.58M1.61M1.82M1.62M1.20M1.50M2.10M481.38K425.44K819.22K11.79M32.29M48.19M
Net Debt1.05M-28.42K2.10M2.44K4.33K1.04M1.51M1.51M1.37M2.53M1.36M2.37M1.54M1.08M1.64M784.62K736.81K768.15K-4.51M26.02K-18.23M-8.14M6.64M16.41M31.61M

Cash Flow

Currency: USD1999-12-312000-12-312001-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-627.86K-569.36K-723.86K-548.46K-624.45K-398.97K-380.90K-1.06M-1.30M-1.49M-343.60K-1.23M-1.82M-1.69M-1.20M409.25K-139.86K277.14K-2.17M-4.03M-4.81M-5.55M-3.25M-23.78K6.79M
Investing Cash Flow393.94K-15.05K-71.01K-122.73K-11.99K-16.43K-81.65K-476.77K240-211.10K-1.34M371.84K-29.89K-8.45K-5.33K-3.03K-85.88K-8.48K-1.20M-2.74M-5.28M-3.51M-10.21M-6.61M-8.36M
Financing Cash Flow56.02K588.24K757.42K678.69K631.38K648.87K227.03K1.54M1.29M1.76M1.63M896.60K1.85M2.17M867.12K244.93K-144.55K-208.10K9.80M622.33K28.30M-627.35K9.64M17.37M-8.48M
Capital Expenditure29.63K048.22K38.78K11.99K16.43K81.65K00211.10K0029.89K8.07K5.33K3.03K85.88K8.48K1.71M1.64M750.45K747.01K265.25K229.30K4.63M
Free Cash Flow-657.48K-569.36K-772.08K-587.24K-636.44K-415.40K-462.55K-1.06M-1.30M-1.28M-343.60K-1.23M-1.85M-1.69M-1.21M406.22K-225.74K268.66K-3.87M-5.68M-5.56M-6.30M-3.51M-253.08K2.16M
Dividends Paid--------370.62K------46.15K32.49K223.11K10.00M583.00K442.52K220.00K---
FCF to OCF104.72%100.00%106.66%107.07%101.92%104.12%121.44%100.00%100.00%85.86%100.00%100.00%101.64%100.48%100.44%99.26%161.40%96.94%178.68%140.76%115.59%113.45%108.17%1064.09%31.84%
Dividend Paid to FCF---------28.61%------11.36%-14.39%83.05%-258.19%-10.27%-7.95%-3.49%---

Earnings

Report DateMar 31, 1998Jun 30, 1998Sep 30, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Aug 22, 2011Nov 14, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Aug 11, 2016Nov 10, 2016Mar 31, 2017May 15, 2017Aug 14, 2017Nov 16, 2017Mar 29, 2018May 15, 2018Aug 13, 2018Nov 14, 2018Mar 31, 2019May 20, 2019Aug 14, 2019Nov 14, 2019Mar 26, 2020May 12, 2020Aug 13, 2020Nov 13, 2020Mar 30, 2021May 14, 2021Aug 16, 2021Nov 12, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Mar 20, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 25, 2024May 13, 2024Aug 12, 2024Nov 12, 2024Mar 24, 2025May 14, 2025Aug 13, 2025Nov 12, 2025Mar 24, 2026Apr 1, 2026Aug 11, 2026Nov 11, 2026
EPS Estimate-------------------------------------------------2.00-1.00--------------------------------------0.17-0.12-0.18-0.27-0.41-0.28-0.32-0.26-0.33-0.13-0.04-0.13-0.07-0.21-0.62-0.12-0.50-0.44-0.210.110.330.020.06
EPS Actual-21.300.34-212.81-31.85-14.97-10.83-16.04-60.37-43.92-16.23-37.36-94.87-73.09-111.7025.38-0.05-0.67-2.92-24.00-1.48-2.02-60.51-2.19-1.19-2.31-0.75-0.71-0.81-0.92-0.87-1.27-1.07-0.10-0.78-1.41-2.10-1.18-1.36-4.00-1.87-1.16-0.94-4.00-3.67-1.89-7.89-5.77-6.97-6.00-2.000.49-0.05-2.20-1.07-1.34-0.04-2.10-1.77-0.69-0.96-0.83-0.38-0.18-0.59-0.23-0.480.02-1.000.05-0.000.020.03-0.080.040.040.010.010.09-0.07-0.39-0.15-0.35-0.44-0.39-0.18-0.18-0.04-0.17-0.16-0.27-0.48-0.41-0.42-0.18-0.38-0.14-0.22-0.13-0.03-0.21-0.41-0.34-0.18-0.41-0.23-3.52-0.190.040.05-
Surprise-------------------------------------------------200.00%-100.00%-------------------------------------0.00%-33.33%-50.00%-77.78%0.00%-50.00%43.75%-46.15%57.58%-69.23%-225.00%76.92%-200.00%-95.24%45.16%-56.52%18.00%47.73%-1576.19%-272.73%-87.69%150.00%-
Timing--------------------------------------------------------------------Pre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap322.50M
Enterprise Value356.07M
Trailing P/E0.00
Forward P/E217.39
Price / Sales2.94
Price / Book40.66
EPS-0.04
Book Value0.864
Revenue (TTM)109.81M
Gross Profit (TTM)102.16M
EBITDA12.75M
Profit Margin-29.15%
Operating Margin6.33%
Return on Equity-1.32%
Return on Assets7.64%
Shares Outstanding9.19M
Shares Float3.77M
Beta1.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 35.00
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
19.99%
Insiders
47.94%
Retail / Other
32.07%

Top Institutional Holders

  • BlackRock Inc
    228.77K2.56%
  • Vanguard Capital Management, LLC
    151.37K1.69%
  • Royal Bank of Canada
    131.39K1.47%
  • Stonebridge Wealth Management, LLC
    129.45K1.45%
  • Geode Capital Management, LLC
    85.66K0.96%
  • Marshall Wace Asset Management Ltd
    76.28K0.85%
  • Squarepoint Ops LLC
    73.61K0.82%
  • Renaissance Technologies Corp
    64.68K0.72%
  • State Street Corp
    62.69K0.70%
  • AQR Capital Management LLC
    39.94K0.45%
  • Jane Street Group LLC
    38.58K0.43%
  • Citadel Advisors Llc
    36.81K0.41%
  • Northern Trust Corp
    33.26K0.37%
  • BNP Paribas Arbitrage, SA
    27.70K0.31%
  • Qube Research & Technologies
    26.41K0.30%
  • Evernest Financial Advisors LLC
    25.70K0.29%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    148.90K1.66%
  • iShares Russell 2000 ETF
    73.52K0.82%
  • Fidelity Small Cap Index
    36.00K0.40%
  • iShares Russell 2000 Growth ETF
    31.91K0.36%

Dividends

20271×
33.00Jul 29, 2027

Stock Splits

  • May 10, 20191:100
  • Jun 26, 20021:100